CoChat

Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of Aβ by Metal Ion Stripping and Redox Silencing

Open access
Tomasello, Marianna Flora, Di Rosa, Maria Carmela, Naletova, Irina, Sciacca, Michele Francesco Maria, Giuffrida, Alessandro, Maccarrone, Giuseppe, Attanasio, Francesco · 2025 · Bioinorganic Chemistry and Applications

The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disorder associated with cognitive decline and loss of memory. It is postulated that the generation of reactive oxygen species (ROS) in Fenton-like reaction connected with Cu(II)/Cu(I) redox cycling of the Cu(II)-aβ complex can play a key role in the molecular mechanism of neurotoxicity in AD. Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic regulatory peptide that possesses a high affinity for Cu(II) ions. The ability of the peptide Semax to inhibit the copper-catalyzed oxidation of aβ was studied in vitro and discussed. The results indicate that Semax is able to extract Cu(II) from Cu(II)-aβ species as well as to influence the redox cycling of the Cu(II)-aβ complex and decrease the level of associated ROS production. Finally, our data suggest that Semax shows cytoprotective properties for SH-SY5Y cells against oxidative stress induced by copper-catalyzed oxidation of the aβ peptide. This study provides valuable insights into the potential role of Semax in neurodegenerative disorders and into the design of new compounds with therapeutic potential for AD.

Overview

CoChat Summary

## TL;DR

Semax, a synthetic peptide with high affinity for Cu(II), reduced Cu(II)-catalyzed ROS generation and the resulting cytotoxicity of amyloid-β in vitro and in SH-SY5Y neuroblastoma cells. The paper argues this occurs by stripping Cu(II) from Aβ and “redox silencing” the copper, although some ROS production still remained under conditions where Cu(I) chelators were present.

## Key findings

  • In cell-free assays, free Cu(II) caused complete ascorbate consumption and hydroxyl radical production after 30 min, while Aβ reduced both the rate and level of these reactions; Aβ fragments Aβ1–16, Aβ1–28, and Aβ1–40 behaved similarly, with no significant difference reported among them.
  • Adding Semax inhibited Cu(II)-mediated ascorbate oxidation and HO• generation, and when Semax:Cu(II) was preformed, adding Aβ did not restore ascorbate consumption or HO• production; the paper reports a conditional dissociation constant of cKd = 1.3 × 10−15 M for Semax:Cu(II).
  • In the presence of bicinchoninic acid (BCA), Cu(II) was readily reduced to Cu(I)-(BCA)2; however, if Cu(II)-Semax was already formed, reduction did not occur and no Cu(I)-(BCA)2 was detected after BCA addition.
  • In SH-SY5Y cells, Cu(II) + ascorbate and Cu(II) + ascorbate + Aβ increased ROS-positive cells to 68% and 79%, respectively, versus about 10% in untreated cells; Semax reduced these to 41% and 40%. Cell viability dropped to 59% and 63% with Cu(II) + ascorbate and Cu(II) + ascorbate + Aβ, and Semax raised viability to 83% and 82%.

## Methods

  • The study combined in vitro spectrophotometric and fluorometric assays with cell-based experiments to test how Semax affects Cu(II)-Aβ redox chemistry and oxidative toxicity.
  • Peptides used included Semax, Aβ1–16, Aβ1–28, and Aβ1–40; SH-SY5Y human neuroblastoma cells were used for intracellular ROS detection and MTT viability assays.
  • Main analyses included UV monitoring of ascorbate consumption, fluorescence detection of hydroxyl radical formation via 3-CCA/7-OH-CCA, UV-Vis competition experiments with BCA, flow cytometry with H2DCFDA for intracellular ROS, and MTT assay for cell viability; results were analyzed with one-way ANOVA/Tukey or chi-square tests.

## Limitations

  • The paper states that Semax did not completely inhibit the Fenton–Haber–Weiss reaction in some conditions; even with Semax, “a small, but significant” consumption of ascorbate and production of OH• persisted.
  • The text makes evident that several conclusions are based on in vitro chemistry and a single neuroblastoma cell line, so direct evidence in animal models or patients is not provided in this paper (evident from the reported methods/results).

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1155/bca/4226220

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 (a) Ascorbate (150 μM) consumption when alone (black curve), in presence of 20 μM Cu2+ (red curve), and in presence of both 20 μM aβ1–40 and 20 μM Cu2+ (blue curve). (b) Formation of OH• measured by fluorescence of 7-OH-CCA formed in presence of 150 μM ascorbate alone (black curve), in presence of 150 μM ascorbate + 20 μM Cu2+ (red curve), and in presence of 150 μM ascorbate + 20 μM aβ1–40 + 20 μM Cu2+ (blue curve). All measurements were performed in 10 mM phosphate buffer, pH = 7.4.
Figure 1 (a) Ascorbate (150 μM) consumption when alone (black curve), in presence of 20 μM Cu2+ (red curve), and in presence of both 20 μM aβ1–40 and 20 μM Cu2+ (blue curve). (b) Formation of OH• measured by fluorescence of 7-OH-CCA formed in presence of 150 μM ascorbate alone (black curve), in presence of 150 μM ascorbate + 20 μM Cu2+ (red curve), and in presence of 150 μM ascorbate + 20 μM aβ1–40 + 20 μM Cu2+ (blue curve). All measurements were performed in 10 mM phosphate buffer, pH = 7.4.CC BY · PubMed Central
Figure 2 (a) Ascorbate (150 μM) consumption in presence of 25 μM Semax + 20 μM Cu2+ (black curve), in presence of the preformed 20 μM complex (Semax − Cu2+) + 20 μM aβ1–40 (green curve), in presence of 20 μM (aβ1–40 − Semax) + 20 μM Cu2+ (blue curve), and in presence of 25 μM Semax added after 5 min at the preformed complex 20 μM (aβ1–40 − Cu2+). (b) Formation of OH• measured by fluorescence of 7-OH-CCA formed in presence of 150 μM ascorbate alone (black curve), in presence of the preformed 20 μM complex (Semax − Cu2+) + 20 μM aβ1–40 (green curve), and in presence of 25 μM Semax added after 5 min at the preformed complex 20 μM (aβ1–40 − Cu2+). All measurements were performed in 10 mM phosphate buffer, pH = 7.4.
Figure 2 (a) Ascorbate (150 μM) consumption in presence of 25 μM Semax + 20 μM Cu2+ (black curve), in presence of the preformed 20 μM complex (Semax − Cu2+) + 20 μM aβ1–40 (green curve), in presence of 20 μM (aβ1–40 − Semax) + 20 μM Cu2+ (blue curve), and in presence of 25 μM Semax added after 5 min at the preformed complex 20 μM (aβ1–40 − Cu2+). (b) Formation of OH• measured by fluorescence of 7-OH-CCA formed in presence of 150 μM ascorbate alone (black curve), in presence of the preformed 20 μM complex (Semax − Cu2+) + 20 μM aβ1–40 (green curve), and in presence of 25 μM Semax added after 5 min at the preformed complex 20 μM (aβ1–40 − Cu2+). All measurements were performed in 10 mM phosphate buffer, pH = 7.4.CC BY · PubMed Central
Figure 3 (a) UV spectra of 150 μM ascorbate + 52 μM BCA solution (black curve) and 150 μM ascorbate + 52 μM BCA after addition of 20 μM Cu(II) (red curve). The BCA contribution is subtracted by the reported UV spectra. Inset: Vis spectra of the Cu(I)-(BCA)2 complex formation immediately after Cu(II) addition (red curve) and after 30 min (blue dot). (b) UV-Vis spectra of 25 μM Semax (black curve), 25 μM Semax + 150 μM ascorbate + 52 μM BCA solution (red curve), 25 μM Semax + 150 μM ascorbate + 52 μM BCA solution immediately after addition of 20 μM Cu(II) (blue curve), and 25 μM Semax + 150 μM ascorbate + 52 μM BCA solution after 30 min from the addition of 20 μM Cu(II) (green dot). (c) Vis spectra of 150 μM Semax (black curve), 150 μM ascorbate + 20 μM Semax-Cu(II) (red curve), 150 μM ascorbate + 20 μM Semax-Cu(II) + 52 μM BCA (blue curve), and 150 μM ascorbate + 20 μM Semax-Cu(II) after 30 min from the addition of 52 μM BCA (green curve). All measurements were performed in 10 mM phosphate buffer, pH = 7.4.
Figure 3 (a) UV spectra of 150 μM ascorbate + 52 μM BCA solution (black curve) and 150 μM ascorbate + 52 μM BCA after addition of 20 μM Cu(II) (red curve). The BCA contribution is subtracted by the reported UV spectra. Inset: Vis spectra of the Cu(I)-(BCA)2 complex formation immediately after Cu(II) addition (red curve) and after 30 min (blue dot). (b) UV-Vis spectra of 25 μM Semax (black curve), 25 μM Semax + 150 μM ascorbate + 52 μM BCA solution (red curve), 25 μM Semax + 150 μM ascorbate + 52 μM BCA solution immediately after addition of 20 μM Cu(II) (blue curve), and 25 μM Semax + 150 μM ascorbate + 52 μM BCA solution after 30 min from the addition of 20 μM Cu(II) (green dot). (c) Vis spectra of 150 μM Semax (black curve), 150 μM ascorbate + 20 μM Semax-Cu(II) (red curve), 150 μM ascorbate + 20 μM Semax-Cu(II) + 52 μM BCA (blue curve), and 150 μM ascorbate + 20 μM Semax-Cu(II) after 30 min from the addition of 52 μM BCA (green curve). All measurements were performed in 10 mM phosphate buffer, pH = 7.4.CC BY · PubMed Central
Figure 4 (a) Cells were treated as discussed in the experimental section and ROS monitored by measuring the DCF fluorescence by flow cytometry. Conditions were: 20 μM Cu(II), 300 μM ascorbate, 25 μM aβ, 25 µM Semax, and 100 μM H2O2 as a positive control. Histograms are representative for three sets of independent experiments, each performed in triplicate and based on 20,000 events for each sample. Bars: mean ± SEM; ∗ indicates a significant difference (p < 0.001, χ2 test). (b, c) Representative curves showing the distribution of SH-SY5Y population based on the intensity of DCF signal. Semax clearly lowers the fluorescence increase induced by either Cu(II)-ascorbate and Cu(II) ascorbate-aβ. The M1 gate (region) was chosen considering the fluorescence intensity shift between untreated cells and cells exposed to 100 μM H2O2.
Figure 4 (a) Cells were treated as discussed in the experimental section and ROS monitored by measuring the DCF fluorescence by flow cytometry. Conditions were: 20 μM Cu(II), 300 μM ascorbate, 25 μM aβ, 25 µM Semax, and 100 μM H2O2 as a positive control. Histograms are representative for three sets of independent experiments, each performed in triplicate and based on 20,000 events for each sample. Bars: mean ± SEM; ∗ indicates a significant difference (p < 0.001, χ2 test). (b, c) Representative curves showing the distribution of SH-SY5Y population based on the intensity of DCF signal. Semax clearly lowers the fluorescence increase induced by either Cu(II)-ascorbate and Cu(II) ascorbate-aβ. The M1 gate (region) was chosen considering the fluorescence intensity shift between untreated cells and cells exposed to 100 μM H2O2.CC BY · PubMed Central
Figure 5 Cell viability was measured by MTT assay. SH-SY5Y cells were seeded and treated for 24 h with 20 μM copper/300 μM ascorbate or 20 μM copper/300 μM/20 µM aβ in the absence (black series) or presence (red series) of 25 μM Semax. Changes in the reductase activity are expressed as percentage to the control made using peptide-free vehicle (PBS). Values represent the mean ± SEM of three independent experiments performed in triplicate. ∗ indicates significance at p < 0.05 vs. Ctrl. # indicates significance of Semax reversion vs. the value produced by the same respective treatment in absence of Semax (one-way ANOVA + Tukey's multiple comparison test). The inset shows the MTT values for the negative controls (300 μM ascorbate alone, and 20 μM aβ: no cytotoxicity reported in this conditions) and the positive control (100 μM H2O2: ROS-induced cell death).
Figure 5 Cell viability was measured by MTT assay. SH-SY5Y cells were seeded and treated for 24 h with 20 μM copper/300 μM ascorbate or 20 μM copper/300 μM/20 µM aβ in the absence (black series) or presence (red series) of 25 μM Semax. Changes in the reductase activity are expressed as percentage to the control made using peptide-free vehicle (PBS). Values represent the mean ± SEM of three independent experiments performed in triplicate. ∗ indicates significance at p < 0.05 vs. Ctrl. # indicates significance of Semax reversion vs. the value produced by the same respective treatment in absence of Semax (one-way ANOVA + Tukey's multiple comparison test). The inset shows the MTT values for the negative controls (300 μM ascorbate alone, and 20 μM aβ: no cytotoxicity reported in this conditions) and the positive control (100 μM H2O2: ROS-induced cell death).CC BY · PubMed Central

Verification

Claims the paper makes

1 Valid · 0 Not valid · 3 Not checked · 18 Own results and interpretations

9 more claims

Create a free account to see all 22 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 7
  • Probably not a substantial claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Metadata

Authors
Tomasello, M. F., Di Rosa, M. C., Naletova, I., Sciacca, M. F. M., Giuffrida, A., Maccarrone, G., & Attanasio, F.
Affiliations
  • National Research Council (IT)
  • University of Catania (IT)
Corresponding author
Attanasio, Francesco
Venue
Bioinorganic Chemistry and Applications
Publisher
Wiley
Published
2025-01
Volume
2025
Issue
1
Pages
4226220-4226220
ISSN
  • 1565-3633 (ISSN-L)
  • 1687-479X
OpenAlex
W4410974228
Cited by
3
References
102
Citations by year
2026: 3
FWCI
1.57
Type
journal article
Language
en
Open access
Licence
Locations
  • Bioinorganic Chemistry and Applications (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
Keywords
Semax, Alzheimer's disease, amyloid-beta, Fenton-like reaction, reactive oxygen species, oxidative stress, SH-SY5Y cells, neuroprotection

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.